Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company

On Wednesday, SynAct Pharma appointed Anders Dyhr Toft as its Chief Medical Officer (CMO). This will come into effect on Aug. 1, according to a company press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk launches smart insulin pen in Denmark
For subscribers